The closing price of Alaunos Therapeutics Inc. (NASDAQ: TCRT) was $0.60 for the day, down -6.25% from the previous closing price of $0.64. In other words, the price has decreased by -$0.0400 from its previous closing price. On the day, 736800 shares were traded. TCRT stock price reached its highest trading level at $0.6470 during the session, while it also had its lowest trading level at $0.6000.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Our analysis of TCRT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.20 and its Current Ratio is at 2.20. In the meantime, Its Debt-to-Equity ratio is 0.37 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 29 when Vieser Jaime bought 1,250,000 shares for $0.65 per share. The transaction valued at 812,500 led to the insider holds 1,250,000 shares of the business.
Postma Robert W bought 750,000 shares of TCRT for $487,500 on Nov 29. The Director now owns 5,000,000 shares after completing the transaction at $0.65 per share.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TCRT now has a Market Capitalization of 137.16M and an Enterprise Value of 117.61M. For the stock, the TTM Price-to-Sale (P/S) ratio is 47.78 while its Price-to-Book (P/B) ratio in mrq is 5.00. Its current Enterprise Value per Revenue stands at 40.25 whereas that against EBITDA is -3.69.
Stock Price History:
Over the past 52 weeks, TCRT has reached a high of $4.01, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is 0.5662, while the 200-Day Moving Average is calculated to be 1.0611.
TCRT traded an average of 624.61K shares per day over the past three months and 626.89k shares per day over the past ten days. A total of 239.68M shares are outstanding, with a floating share count of 218.77M. Insiders hold about 1.40% of the company’s shares, while institutions hold 33.10% stake in the company. Shares short for TCRT as of Apr 27, 2023 were 23.88M with a Short Ratio of 23.88M, compared to 23.5M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 9.92% and a Short% of Float of 10.38%.
The firm’s stock currently is rated by 6 analysts. On average, analysts expect EPS of -$0.04 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.05, while EPS last year was -$0.05. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.16 and -$0.19 for the fiscal current year, implying an average EPS of -$0.17. EPS for the following year is -$0.13, with 6 analysts recommending between $0.22 and -$0.29.